The Mount Sinai Institute for Next Generation Healthcare is a new model of research, innovation and market delivery founded in 2016 to expedite and help shape the impending revolution in healthcare. Our vision of next generation healthcare harnesses cutting edge science, technology and analytics to enhance the health and vitality of people everywhere.
Several factors are converging to force dramatic change in the healthcare landscape:
- Chronic conditions are taking a toll on populations globally and exert massive financial strains on states and institutions
- Patients are being empowered by information and technology
- The market for healthcare delivery is shifting from a hospital-centric model to a patient-centric model
- People have increasing cultural and financial incentives to focus on staying healthy and avoid excess treatments and procedures
- Genomics and other profiling technologies are revealing the tremendous molecular complexity of diseases such as Alzheimer’s, diabetes, cancers and heart diseases
Meanwhile, transformational technologies including artificial intelligence, robotics, genomic sequencing, sensors and wearable devices, Internet of Things, and cloud computing offer unprecedented opportunities to solve global health challenges.
Experts all agree that a profound shift in healthcare is inevitable. But how will we navigate the newly available possibilities, who will lead us, and how long must we wait?
Next-generation healthcare will not be reached through incremental evolution of the current system. For this reason, the mission of Mount Sinai’s Institute for Next Generation Healthcare is to transform the world’s experience of healthcare through an integrated model of research, delivery and innovation that is patient-centric and informed by large-scale data science.
Our model integrates activities across three different locations, each of which leverages its unique strengths:
- Our renowned group of scientists at the Icahn School of Medicine at Mount Sinai generates knowledge that fuels technological innovation and new models for clinical care
- The Manhattan-based clinic is the first of its kind to translate new discoveries from computational data-driven approaches into personalized healthcare delivery to patients
- The Silicon Valley Campus focuses on health data and design innovations and go-to-market delivery systems.
The model of the future is a technology-enabled platform designed to capture and integrate the abundance of data from multiple sources, yielding tremendous value for researchers, medical practitioners and individuals trying to understand how best to manage their own health and well-being. Participants in our clinical trials engage with our scientists and data analysts in a dynamic feedback loop, allowing for real-time exploration and the advancement of knowledge and practice. This approach reduces the gap between what we know and what we do in a way that accelerates progress in human health and well-being globally.
Areas of Focus
Our areas of focus are based on several important criteria:
- They have been neglected, because they have appeared insoluble, but are now tractable, given recent scientific advances.
- They require advanced tools, data, and emerging technologies to understand and to develop scalable solutions.
- They represent a significant burden on populations across socio-economic lines.
- Their cost places a high financial burden on society.
Why Mount Sinai
We are not alone in researching and innovating on the front lines of healthcare. Many world-class scientists, programs, and institutions are pursuing the scent of massive disruption just around the corner. However, the Institute for Next Generation Healthcare has a number of advantages over other efforts. Few other places can claim the infrastructure, patient base and scientific expertise necessary to transform the way medicine of the near future will be practiced and delivered, let alone how it can be modeled and scaled for global communities. We have quickly become a world leader in data science, informatics, and genomics through strategic investments of over $100 million to improve our scientific computational infrastructure and recruit world class talent. We can leverage our access to nearly 4 million patients annually to learn about the needs of diverse populations, personalize our clinical trials and improve outcomes. Our base of scientific expertise spans all the critical domains needed to build an integrated perspective on human health, including genetics, microbiology, immunology and data science.